Issue Navigation
-
Review
-
112-122
Monoamine oxidases in major depressive disorder and alcoholism.
Duncan J, Johnson S, Ou XM
Drug Discov Ther. 2012; 6(3):112-122.
DOI: 10.5582/ddt.2012.v6.3.112
-
123-132
Improved treatment of nicotine addiction and emerging pulmonary drug delivery.
Islam N, Rahman S
Drug Discov Ther. 2012; 6(3):123-132.
DOI: 10.5582/ddt.2012.v6.3.123
-
133-139
Synthesis and anticancer activity of novel 5-(indole-2-yl)-3-substituted 1,2,4-oxadiazoles.
Wang P, Liu JZ, Xing HL, Liu Y, Xie WC, Zhao GS
Drug Discov Ther. 2012; 6(3):133-139.
DOI: 10.5582/ddt.2012.v6.3.133
-
140-146
Time and dose-response effects of honokiol on UVB-induced skin cancer development.
Guillermo RF, Chilampalli C, Zhang X, Zeman D, Fahmy H, Dwivedi C
Drug Discov Ther. 2012; 6(3):140-146.
DOI: 10.5582/ddt.2012.v6.3.140
-
147-156
Hussein A, Ahmed AAE, Shouman SA, Sharawy S
Drug Discov Ther. 2012; 6(3):147-156.
DOI: 10.5582/ddt.2012.v6.3.147
-
157-162
Kubota T
Drug Discov Ther. 2012; 6(3):157-162.
DOI: 10.5582/ddt.2012.v6.3.157
-
163-168
Effect of surfactant on lycopene-loaded nanostructured lipid carriers.
Riangjanapatee P, Okonogi S
Drug Discov Ther. 2012; 6(3):163-168.
DOI: 10.5582/ddt.2012.v6.3.163